Cheng Liming, Feng Bo, Xie Chao, Chen Chunyan, Guo Linghui
Department of Anesthesia, Kunming Children's Hospital, Kunming, Yunnan, China.
Immunol Invest. 2025 Feb;54(2):250-270. doi: 10.1080/08820139.2024.2434049. Epub 2024 Dec 3.
Sepsis is a syndrome of the systemic inflammatory response caused by infection that can endanger a patient's life. The aim of this study was to explore the molecular mechanism by which bone marrow mesenchymal stem cells-derived exosomes (BMSCs-exo) carrying miR-20a-5p regulate the progression of sepsis.
Clinical samples from sepsis patients were collected. Mouse and cell models of sepsis were induced by lipopolysaccharide (LPS). The levels of related genes and proteins were determined by RT‒qPCR, Western blotting and ELISA. CCK-8 and flow cytometry assays were used to assess cell viability, apoptosis, and markers of macrophage polarization.
In septic patients, miR-20a-5p levels were significantly lower and CXCL12 expression was significantly increased. After LPS induction, M2 polarization of macrophages was significantly reduced, the level of inflammatory factors was increased, and apoptosis was increased. The addition of BMSCs-exo increased the miR-20a-5p level and decreased the expression of CXCL12 in macrophages, thereby promoting macrophage M2 polarization and reducing the levels of inflammatory factors.
This study demonstrated for the first time that BMSCs-exo promoted the polarization of M2 macrophages through the miR-20a-5p/CXCL12 axis, thus alleviating the development of sepsis. These findings provide a new theoretical basis for the targeted treatment of sepsis with exosomes or miR-20a-5p.
脓毒症是由感染引起的全身炎症反应综合征,可危及患者生命。本研究旨在探讨携带miR-20a-5p的骨髓间充质干细胞外泌体(BMSCs-exo)调节脓毒症进展的分子机制。
收集脓毒症患者的临床样本。通过脂多糖(LPS)诱导建立小鼠和细胞脓毒症模型。采用RT-qPCR、蛋白质免疫印迹法和酶联免疫吸附测定法测定相关基因和蛋白质水平。使用CCK-8和流式细胞术检测评估细胞活力、细胞凋亡及巨噬细胞极化标志物。
脓毒症患者中,miR-20a-5p水平显著降低,CXCL12表达显著增加。LPS诱导后,巨噬细胞的M2极化显著降低,炎症因子水平升高,细胞凋亡增加。添加BMSCs-exo可提高巨噬细胞中miR-20a-5p水平,降低CXCL12表达,从而促进巨噬细胞M2极化并降低炎症因子水平。
本研究首次证明BMSCs-exo通过miR-20a-5p/CXCL12轴促进M2巨噬细胞极化,从而减轻脓毒症的发展。这些发现为外泌体或miR-20a-5p靶向治疗脓毒症提供了新的理论依据。